Brain & Behavior Research Foundation Comments on FDA Approval of New Depression Treatment - P&T Community

Brain & Behavior Research Foundation Comments on FDA Approval of New Depression Treatment  P&T CommunityNEW YORK, March 6, 2019 /PRNewswire/ -- The Brain & Behavior Research Foundation (BBRF) applauds the FDA for its approval of Esketamine nasal spray ...